Biotech Dealmaking - Regulatory Considerations for the Next Wave of Development-Stage Transactions - Program and Lunch

La Mar | 1 1/2 Ferry Plaza, San Francisco

11:30 a.m. - 2:30 p.m. PT

For questions, please contact sfevents@sidley.com.

Monday, January 12, 2026

Torrey Cope | Meenakshi Datta | Sally Wagner Partin

Join members of Sidley's Global Life Sciences team for a lunchtime CLE-accredited program during the JPM Healthcare Conference discussing the latest regulatory trends impacting the next wave of development-stage transactions.

Led by Meena Datta, global co-leader of Sidley's Healthcare practice; Torrey Cope, partner in Sidley's Food Drug and Medical Device (FDMD) practice; and Sally Wagner Partin, partner in Sidley's M&A practice, this session provides keen insights on the considerations driving recent biotech dealmaking. 1 hour CLE credit available.

Contacts

Torrey Cope

Partner

tcope@sidley.com +1 202 736 8803

Washington, D.C.
Meenakshi Datta

Partner

mdatta@sidley.com +1 312 853 7169

Chicago
Sally Wagner Partin

Partner

swagnerpartin@sidley.com +1 415 772 7478 +1 650 565 7578

San Francisco, Palo Alto

Offices

San Francisco